bis(thiazol-5-ylmethyl) 2,6-dimethyl-4-(1-methyl-1H-indazol-5-yl)-1,4-dihydropyridine-3,5-dicarboxylate

ID: ALA5208410

Chembl Id: CHEMBL5208410

PubChem CID: 168297064

Max Phase: Preclinical

Molecular Formula: C25H23N5O4S2

Molecular Weight: 521.62

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1=C(C(=O)OCc2cncs2)C(c2ccc3c(cnn3C)c2)C(C(=O)OCc2cncs2)=C(C)N1

Standard InChI:  InChI=1S/C25H23N5O4S2/c1-14-21(24(31)33-10-18-8-26-12-35-18)23(16-4-5-20-17(6-16)7-28-30(20)3)22(15(2)29-14)25(32)34-11-19-9-27-13-36-19/h4-9,12-13,23,29H,10-11H2,1-3H3

Standard InChI Key:  DIBLXUOREHSWCN-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5208410

    ---

Associated Targets(Human)

PDE1C Tclin Phosphodiesterase 1C (228 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 521.62Molecular Weight (Monoisotopic): 521.1191AlogP: 4.21#Rotatable Bonds: 7
Polar Surface Area: 108.23Molecular Species: NEUTRALHBA: 11HBD: 1
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 2.72CX LogP: 2.35CX LogD: 2.35
Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.36Np Likeness Score: -0.85

References

1. Huang MX, Tian YJ, Han C, Liu RD, Xie X, Yuan Y, Yang YY, Li Z, Chen J, Luo HB, Wu Y..  (2022)  Structural Modifications of Nimodipine Lead to Novel PDE1 Inhibitors with Anti-pulmonary Fibrosis Effects.,  65  (12.0): [PMID:35666471] [10.1021/acs.jmedchem.2c00458]

Source